Standard set of patient-reported outcomes for personality disorder.


Journal

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
ISSN: 1573-2649
Titre abrégé: Qual Life Res
Pays: Netherlands
ID NLM: 9210257

Informations de publication

Date de publication:
Dec 2021
Historique:
accepted: 03 05 2021
pubmed: 3 6 2021
medline: 26 11 2021
entrez: 2 6 2021
Statut: ppublish

Résumé

The purpose of the article is to present standard set of outcomes for people with personality disorder (PD), in order to facilitate patient outcome measurement worldwide. The International Consortium for Health Outcomes Measurement (ICHOM) gathered a multidisciplinary international working group, consisting of 16 experts, including clinicians, nurses, psychologists, methodologists and patient representatives, to develop a standard set of outcome measures for people with PD. The Delphi method was used to reach consensus on the scope of the set, outcome domains, outcome measures, case-mix variables and time points for measuring outcomes in service users. For each phase, a project team prepared materials based on systematic literature reviews and consultations with experts. The working group decided to include PD, as defined by International Classification of Diseases 11th revision (ICD-11). Eleven core outcomes and three optional outcomes across four health domains (mental health, behaviour, functioning and recovery) were defined as those relevant for people with PD. Validated measures for the selected outcomes were selected, some covering more than one outcome. Case-mix variables were aligned to other ICHOM mental health standard sets and consisted of demographic factors and those related to the treatment that people received. The group recommended that most outcomes are measured at baseline and annually. The international minimum standard set of outcomes has the potential to improve clinical decision making through systematic measurement and comparability. This will be key in improving the standard of health care for people with PD across the world.

Identifiants

pubmed: 34075531
doi: 10.1007/s11136-021-02870-w
pii: 10.1007/s11136-021-02870-w
pmc: PMC8602216
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3485-3500

Informations de copyright

© 2021. The Author(s).

Références

Am J Psychiatry. 2011 Dec;168(12):1266-77
pubmed: 22193671
Qual Life Res. 2009 Feb;18(1):125-36
pubmed: 19152119
Dialogues Clin Neurosci. 2014 Jun;16(2):255-66
pubmed: 25152662
Br J Psychiatry. 2010 May;196(5):389-95
pubmed: 20435966
Qual Life Res. 2010 Dec;19(10):1487-500
pubmed: 20668950
BMC Psychiatry. 2016 Jul 08;16:224
pubmed: 27391323
Br J Psychiatry. 2010 Jan;196(1):4-12
pubmed: 20044651
N Engl J Med. 2013 Nov 28;369(22):2079-81
pubmed: 24195500
Br J Psychiatry. 2008 Oct;193(4):342-3
pubmed: 18827303
Cochrane Database Syst Rev. 2020 May 4;5:CD012955
pubmed: 32368793
Eur Urol. 2015 Mar;67(3):460-7
pubmed: 25234359
Indian J Psychol Med. 2018 Nov-Dec;40(6):517-527
pubmed: 30533947
Borderline Personal Disord Emot Dysregul. 2014 Apr 10;1:3
pubmed: 26843958
Br J Psychiatry. 2018 Jan;212(1):42-49
pubmed: 29433611
Personal Disord. 2016 Apr;7(2):192-7
pubmed: 26595344
J Psychopathol Behav Assess. 2016 Jun;38(2):284-296
pubmed: 27239096
Cleft Palate Craniofac J. 2017 Sep;54(5):540-554
pubmed: 27223626
Arthritis Care Res (Hoboken). 2019 Dec;71(12):1556-1565
pubmed: 30358135
JAMA Oncol. 2017 May 1;3(5):677-685
pubmed: 28033439
Psychol Psychother. 2019 Dec;92(4):441-464
pubmed: 30099834
Borderline Personal Disord Emot Dysregul. 2019 May 21;6:9
pubmed: 31143448
BMC Health Serv Res. 2018 Dec 11;18(1):953
pubmed: 30537958
Br J Psychiatry. 2002 Jul;181:62-6
pubmed: 12091265
Br J Psychiatry. 2020 Feb;216(2):69-78
pubmed: 31298170
N Engl J Med. 2016 Feb 11;374(6):504-6
pubmed: 26863351
Cochrane Database Syst Rev. 2016 Jul 13;7:CD011119
pubmed: 27409972
World Psychiatry. 2017 Jun;16(2):215-216
pubmed: 28498598
Borderline Personal Disord Emot Dysregul. 2015 Jan 24;2:1
pubmed: 26401304
Qual Life Res. 2016 Mar;25(3):615-24
pubmed: 26353907
Cochrane Database Syst Rev. 2012 Aug 15;(8):CD005652
pubmed: 22895952
J Neuropsychiatry Clin Neurosci. 1991 Spring;3(2):S57-60
pubmed: 1821223
N Engl J Med. 2010 Dec 23;363(26):2477-81
pubmed: 21142528
Qual Life Res. 2017 Dec;26(12):3211-3225
pubmed: 28786017
Lancet. 2015 Feb 21;385(9969):727-34
pubmed: 25706218

Auteurs

Valentina Prevolnik Rupel (V)

Institute for Economic Research, Kardeljeva ploščad 17, 1000, Ljubljana, Slovenia. rupelv@ier.si.

Beth Jagger (B)

International Consortium for Health Outcomes Measurement, Cambridge, USA.

Luz Sousa Fialho (LS)

International Consortium for Health Outcomes Measurement, Cambridge, USA.

Lisa-Marie Chadderton (LM)

International Consortium for Health Outcomes Measurement, Cambridge, USA.

Timea Gintner (T)

International Consortium for Health Outcomes Measurement, Cambridge, USA.

Anroud Arntz (A)

University of Amsterdam, Amsterdam, The Netherlands.

Åse-Line Baltzersen (ÅL)

Patient Representative, The Norwegian National Advisory Unit On Personality Psychiatry, Oslo, Norway.

Julia Blazdell (J)

The Institute of Mental Health, WLMHT Managed Clinical Network, Southall, UK.

Jan van Busschbach (J)

Erasmus MC, Rotterdam, The Netherlands.

Marika Cencelli (M)

Patient Representative, London, UK.

Andrew Chanen (A)

The University of Melbourne, Melbourne, Australia.
Orygen, Melbourne, Australia.

Charlotte Delvaux (C)

Patient representative, Te gek!?, Ghent, Belgium.

Fieke van Gorp (F)

Patient Representative, Ghent, Belgium.

Lucie Langford (L)

University of Toronto, Toronto, Canada.

Brian McKenna (B)

Auckland University of Technology, Auckland, New Zealand.
Swinburne University of Technology, Melbourne, Australia.

Paul Moran (P)

University of Bristol, Bristol, UK.

Karla Pacheco (K)

Tecnologico de Monterrey, Monterrey, Mexico.

Carla Sharp (C)

University of Houston, Houston, USA.

Wei Wang (W)

Norwegian University of Science and Technology (NTNU), Trondheim, Norway.

Karen Wright (K)

University of Central Lancashire, Preston, UK.

Mike J Crawford (MJ)

Imperial College, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH